These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2997 related articles for article (PubMed ID: 32727811)

  • 1. SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity.
    Wei J; Zhao J; Han M; Meng F; Zhou J
    J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32727811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-BCMA CAR T administration in a relapsed and refractory multiple myeloma patient after COVID-19 infection: a case report.
    Madduri D; Parekh S; Campbell TB; Neumann F; Petrocca F; Jagannath S
    J Med Case Rep; 2021 Feb; 15(1):90. PubMed ID: 33608053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pro- and Anti-Inflammatory Responses in Severe COVID-19-Induced Acute Respiratory Distress Syndrome-An Observational Pilot Study.
    Notz Q; Schmalzing M; Wedekink F; Schlesinger T; Gernert M; Herrmann J; Sorger L; Weismann D; Schmid B; Sitter M; Schlegel N; Kranke P; Wischhusen J; Meybohm P; Lotz C
    Front Immunol; 2020; 11():581338. PubMed ID: 33123167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of SARS-CoV-2-Specific Humoral and Cellular Immunity in COVID-19 Convalescent Individuals.
    Ni L; Ye F; Cheng ML; Feng Y; Deng YQ; Zhao H; Wei P; Ge J; Gou M; Li X; Sun L; Cao T; Wang P; Zhou C; Zhang R; Liang P; Guo H; Wang X; Qin CF; Chen F; Dong C
    Immunity; 2020 Jun; 52(6):971-977.e3. PubMed ID: 32413330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expansion of SARS-CoV-2-Specific Antibody-Secreting Cells and Generation of Neutralizing Antibodies in Hospitalized COVID-19 Patients.
    Varnaitė R; García M; Glans H; Maleki KT; Sandberg JT; Tynell J; Christ W; Lagerqvist N; Asgeirsson H; Ljunggren HG; Ahlén G; Frelin L; Sällberg M; Blom K; Klingström J; Gredmark-Russ S
    J Immunol; 2020 Nov; 205(9):2437-2446. PubMed ID: 32878912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndrome.
    Weiskopf D; Schmitz KS; Raadsen MP; Grifoni A; Okba NMA; Endeman H; van den Akker JPC; Molenkamp R; Koopmans MPG; van Gorp ECM; Haagmans BL; de Swart RL; Sette A; de Vries RD
    Sci Immunol; 2020 Jun; 5(48):. PubMed ID: 32591408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The underpinning biology relating to multiple sclerosis disease modifying treatments during the COVID-19 pandemic.
    Baker D; Amor S; Kang AS; Schmierer K; Giovannoni G
    Mult Scler Relat Disord; 2020 Aug; 43():102174. PubMed ID: 32464584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The laboratory tests and host immunity of COVID-19 patients with different severity of illness.
    Wang F; Hou H; Luo Y; Tang G; Wu S; Huang M; Liu W; Zhu Y; Lin Q; Mao L; Fang M; Zhang H; Sun Z
    JCI Insight; 2020 May; 5(10):. PubMed ID: 32324595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longer Duration of SARS-CoV-2 Infection in a Case of Mild COVID-19 With Weak Production of the Specific IgM and IgG Antibodies.
    Guo X; Zeng L; Huang Z; He Y; Zhang Z; Zhong Z
    Front Immunol; 2020; 11():1936. PubMed ID: 32849650
    [No Abstract]   [Full Text] [Related]  

  • 10. Primary exposure to SARS-CoV-2 protects against reinfection in rhesus macaques.
    Deng W; Bao L; Liu J; Xiao C; Liu J; Xue J; Lv Q; Qi F; Gao H; Yu P; Xu Y; Qu Y; Li F; Xiang Z; Yu H; Gong S; Liu M; Wang G; Wang S; Song Z; Liu Y; Zhao W; Han Y; Zhao L; Liu X; Wei Q; Qin C
    Science; 2020 Aug; 369(6505):818-823. PubMed ID: 32616673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Duration of serum neutralizing antibodies for SARS-CoV-2: Lessons from SARS-CoV infection.
    Lin Q; Zhu L; Ni Z; Meng H; You L
    J Microbiol Immunol Infect; 2020 Oct; 53(5):821-822. PubMed ID: 32249185
    [No Abstract]   [Full Text] [Related]  

  • 12. Recurrent pneumonia in a patient with new coronavirus infection after discharge from hospital for insufficient antibody production: a case report.
    Zhou X; Zhou J; Zhao J
    BMC Infect Dis; 2020 Jul; 20(1):500. PubMed ID: 32652938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term infection of SARS-CoV-2 changed the body's immune status.
    Lin L; Luo S; Qin R; Yang M; Wang X; Yang Q; Zhang Y; Wang Q; Zhu R; Fan H; Wang H; Hu Y; Wang L; Hu D
    Clin Immunol; 2020 Sep; 218():108524. PubMed ID: 32659373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expansion of plasmablasts and loss of memory B cells in peripheral blood from COVID-19 patients with pneumonia.
    De Biasi S; Lo Tartaro D; Meschiari M; Gibellini L; Bellinazzi C; Borella R; Fidanza L; Mattioli M; Paolini A; Gozzi L; Jaacoub D; Faltoni M; Volpi S; Milić J; Sita M; Sarti M; Pucillo C; Girardis M; Guaraldi G; Mussini C; Cossarizza A
    Eur J Immunol; 2020 Sep; 50(9):1283-1294. PubMed ID: 32910469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 infection protects against rechallenge in rhesus macaques.
    Chandrashekar A; Liu J; Martinot AJ; McMahan K; Mercado NB; Peter L; Tostanoski LH; Yu J; Maliga Z; Nekorchuk M; Busman-Sahay K; Terry M; Wrijil LM; Ducat S; Martinez DR; Atyeo C; Fischinger S; Burke JS; Slein MD; Pessaint L; Van Ry A; Greenhouse J; Taylor T; Blade K; Cook A; Finneyfrock B; Brown R; Teow E; Velasco J; Zahn R; Wegmann F; Abbink P; Bondzie EA; Dagotto G; Gebre MS; He X; Jacob-Dolan C; Kordana N; Li Z; Lifton MA; Mahrokhian SH; Maxfield LF; Nityanandam R; Nkolola JP; Schmidt AG; Miller AD; Baric RS; Alter G; Sorger PK; Estes JD; Andersen H; Lewis MG; Barouch DH
    Science; 2020 Aug; 369(6505):812-817. PubMed ID: 32434946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics of four cancer patients with SARS-CoV-2 infection in Wuhan, China.
    Song SH; Chen TL; Deng LP; Zhang YX; Mo PZ; Gao SC; Hu WJ; Xiong Y; Ma ZY
    Infect Dis Poverty; 2020 Jul; 9(1):82. PubMed ID: 32616030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution of Early SARS-CoV-2 and Cross-Coronavirus Immunity.
    Loos C; Atyeo C; Fischinger S; Burke J; Slein MD; Streeck H; Lauffenburger D; Ryan ET; Charles RC; Alter G
    mSphere; 2020 Sep; 5(5):. PubMed ID: 32878931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution of severe acute respiratory syndrome coronavirus 2 RNA test results in a patient with fatal coronavirus disease 2019: a case report.
    Shao C; Liu H; Meng L; Sun L; Wang Y; Yue Z; Kong H; Li H; Weng H; Lv F; Jin R
    Hum Pathol; 2020 Jul; 101():82-88. PubMed ID: 32437706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.
    Conti P; Caraffa A; Tetè G; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G
    J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1629-1632. PubMed ID: 32945158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokine Storm Drugs Move from CAR T to COVID-19.
    Cancer Discov; 2020 Jul; 10(7):OF8. PubMed ID: 32371479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 150.